Resultados de la búsqueda 1261-1270 of 8815 for redness of the internal parts of men

  1. Ensayos clínicos - Hematología

    The purpose of this study is to learn about how platelets adhere to the blood von Willebrand factor and how known clinical mutations that result in bleeding ...

  2. Cirugía pediátrica - Ensayos clínicos

    More than two thirds of affected infants have other birth defects that include other parts of the gastrointestinal tract, airway, heart, skeleton, kidneys, eyes ...

  3. Hematología - Ensayos clínicos

    The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has come ...

  4. Neurocirugía - Ensayos clínicos

    Cohort 1 includes blood collections for in vitro studies which are a component ... Red Informativa · Precios Transparentes · Profesionales médicos.

  5. Ensayos clínicos - Neurología

    The primary purpose of this study is to map the electrophysiological properties of deep brain stimulation (DBS) targets and associated areas by analyzing ...

  6. Obstetricia y Ginecología - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to determine the time from intramuscular injection to the time of first fetal movement after a fetal surgery ...

  7. Eyaculación retrógrada - Mayo Clinic

    Eyaculación retrógrada. Sections. Productos y ... DS00913 IM02696 m7 male retrogradeejacthu jpg. Tu ... Red Informativa · Precios Transparentes ...

  8. Atención ginecológica para hombres trans - Mayo Clinic

    Salud del adulto · Imprimir. Sections ... Durante un examen pélvico, el profesional de atención médica revisa los genitales, palpa el interior de la vagina y ...

  9. Hematología - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  10. Hematología - Ensayos clínicos

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.